Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$103.20

2.27 (2.25%)

07:01
05/15/18
05/15
07:01
05/15/18
07:01

Anylam names Colleen Reitan to board of directors

Alnylam Pharmaceuticals the appointment of Colleen Reitan to Alnylam's Board of Directors, effective June 1, 2018. Ms. Reitan was the prior President of Plan Operations of Health Care Service Corporation, the largest customer-owned health insurer in the United States and an independent licensee of Blue Cross and Blue Shield Association.

  • 15

    May

  • 20

    May

  • 30

    May

  • 11

    Aug

ALNY Alnylam
$103.20

2.27 (2.25%)

04/15/18
PIPR
04/15/18
NO CHANGE
Target $182
PIPR
Overweight
Piper Jaffray confident in Alnylam Givosiran approval
Piper Jaffray analyst Edward Tenthoff notes that Alnylam presented updated Phase I and preliminary OLE data on givosiran in acute hepatic porphyria. The analyst believes the results have strong read-through to the ongoing Phase III ENVISION trial, which is on-track to report interim data in mid'18 that could support an NDA filing by YE18 and accelerated approval in 2019. Tenthoff remains confident in broad patisiran approval in ATTR amyloidosis by the August 11 PDUFA. He reiterates an Overweight rating and $182 price target on the shares.
04/20/18
EVER
04/20/18
NO CHANGE
Target $17
EVER
Outperform
Dicerna price target raised to $17 after Alnylam settlement at Evercore ISI
Evercore ISI analyst Umer Raffat raised his price target on Dicerna (DRNA) to $17 from $14 after news that the company has resolved all litigation with Alnylam Pharmaceuticals (ALNY). "The settlement allows Dicerna to advance all of its key and planned pipeline programs while maintaining a strong balance sheet," the company said in a statement. Raffat maintains an Outperform rating on Dicerna shares.
04/23/18
PIPR
04/23/18
NO CHANGE
Target $182
PIPR
Overweight
Piper reiterates Overweight on Alnylam after orphan designation in Europe
Piper Jaffray analyst Edward Tenthoff reiterates an Overweight rating on Alnylam Pharmaceuticals after the company received a positive opinion in Europe for ALN-TTRsc02 orphan designation to treat ATTR amyloidosis. The analyst finds the recommendation encouraging, noting that ALN-TTRsc02 will advance into a Phase III program by the end of 2018. He remains confident in broad patisiran approval in ATTR amyloidosis by the August 11 FDA action date and expects European approval in the second half of 2018. Tenthoff keeps a $182 price target on Alnylam shares.
05/01/18
HCWC
05/01/18
NO CHANGE
Target $12
HCWC
Neutral
Dicerna litigation settlement could lead to collaborations, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce believes resolving all pending litigation with Alnylam (ALNY) removes an overhang on shares of Dicerna Pharmaceuticals (DRNA). The litigation with Alnylam had created an overhang on business development opportunities, likely causing perhaps three or more potential partners to decline a deal at the time, Arce tells investors in a research note. With the settlement, the analyst believes potential partners are likely to return to the negotiating table. He keeps a Neutral rating on Dicerna with a $12 price target.

TODAY'S FREE FLY STORIES

TLRY

Tilray

$154.99

34.79 (28.94%)

08:55
09/19/18
09/19
08:55
09/19/18
08:55
Hot Stocks
Tilray shares go mad after CEO appears on CNBC's Mad Money »

Shares of Tilray (TLRY),…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$31.93

-0.51 (-1.57%)

, FTV

Fortive

$87.39

0.25 (0.29%)

08:55
09/19/18
09/19
08:55
09/19/18
08:55
Options
Notable open interest changes for September 19th »

Tuesday's total…

AMD

AMD

$31.93

-0.51 (-1.57%)

FTV

Fortive

$87.39

0.25 (0.29%)

BAC

Bank of America

$30.22

-0.05 (-0.17%)

PBR

Petrobras

$11.23

0.305 (2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 23

    Sep

  • 25

    Sep

  • 27

    Sep

AZO

AutoZone

$732.74

-14.79 (-1.98%)

, AAP

Advance Auto Parts

$167.64

4.25 (2.60%)

08:54
09/19/18
09/19
08:54
09/19/18
08:54
Recommendations
AutoZone, Advance Auto Parts, O'Reilly Automotive analyst commentary  »

AutoZone price target…

AZO

AutoZone

$732.74

-14.79 (-1.98%)

AAP

Advance Auto Parts

$167.64

4.25 (2.60%)

ORLY

O'Reilly Automotive

$340.65

3.98 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

TLRY

Tilray

$154.99

34.79 (28.94%)

08:53
09/19/18
09/19
08:53
09/19/18
08:53
Hot Stocks
Citron says still short Tilray, recent rally 'beyond comprehension' »

Short-seller Citron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROW

T. Rowe Price

$109.29

0.3 (0.28%)

08:53
09/19/18
09/19
08:53
09/19/18
08:53
Conference/Events
T. Rowe Price management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

08:53
09/19/18
09/19
08:53
09/19/18
08:53
Conference/Events
Roth Capital to hold a conference »

4th Annual Datacenter…

08:50
09/19/18
09/19
08:50
09/19/18
08:50
Conference/Events
Canaccord to hold a conference »

Artificial Intelligence…

08:50
09/19/18
09/19
08:50
09/19/18
08:50
General news
U.S. Q2 current account deficit narrowed to -$101.5 B »

U.S. Q2 current account…

08:50
09/19/18
09/19
08:50
09/19/18
08:50
General news
Treasury Action: yields drifted below highs »

Treasury Action: yields…

HEAR

Turtle Beach

$17.75

-1.55 (-8.03%)

08:49
09/19/18
09/19
08:49
09/19/18
08:49
Recommendations
Turtle Beach analyst commentary  »

Turtle Beach 45% pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEA

Lear

$154.96

-2.2 (-1.40%)

08:47
09/19/18
09/19
08:47
09/19/18
08:47
Recommendations
Lear analyst commentary  »

Lear price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

TNDM

TNDM

08:47
09/19/18
09/19
08:47
09/19/18
08:47
Conference/Events
Tandem Diabetes management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 27

    Nov

GWPH

GW Pharmaceuticals

$149.14

8.165 (5.79%)

08:47
09/19/18
09/19
08:47
09/19/18
08:47
Recommendations
GW Pharmaceuticals analyst commentary  »

Launch of GW…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

TFX

Teleflex

$269.03

1.81 (0.68%)

08:46
09/19/18
09/19
08:46
09/19/18
08:46
Conference/Events
Teleflex management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 09

    Oct

NVS

Novartis

$85.03

-0.1 (-0.12%)

08:46
09/19/18
09/19
08:46
09/19/18
08:46
Conference/Events
Novartis has a conference call hosted by JPMorgan »

JPMorgan Analyst Vosser …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

SPWH

Sportsman's Warehouse

$6.15

-0.02 (-0.32%)

08:45
09/19/18
09/19
08:45
09/19/18
08:45
Conference/Events
Sportsman's Warehouse management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

08:45
09/19/18
09/19
08:45
09/19/18
08:45
General news
U.S. housing starts rose 9.2% to 1.282 M in August »

U.S. housing starts rose…

SSC

Seven Stars Cloud Group

$4.38

-0.3 (-6.41%)

, CBL

CBL & Associates

$4.34

0.005 (0.12%)

08:45
09/19/18
09/19
08:45
09/19/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

SSC

Seven Stars Cloud Group

$4.38

-0.3 (-6.41%)

CBL

CBL & Associates

$4.34

0.005 (0.12%)

MELI

MercadoLibre

$315.06

-7.02 (-2.18%)

SQQQ

ProShares UltraPro Short QQQ

$11.80

-0.3 (-2.48%)

GERN

Geron

$5.48

0.05 (0.92%)

KEY

KeyCorp

$19.74

-0.11 (-0.55%)

CGC

Canopy Growth

$51.77

3.25 (6.70%)

SGYP

Synergy Pharmaceuticals

$1.69

0.005 (0.30%)

SDS

UltraShort S&P500 ProShares

$33.45

-0.41 (-1.21%)

AMJ

American Medical Laboratories Inc

$27.87

0.04 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 13

    Oct

  • 18

    Oct

  • 30

    Oct

  • 30

    Oct

08:45
09/19/18
09/19
08:45
09/19/18
08:45
General news
FX Action: The dollar »

FX Action: The dollar was…

08:45
09/19/18
09/19
08:45
09/19/18
08:45
General news
U.S. Q2 current account deficit narrowed to -$101.5 B »

U.S. Q2 current account…

ATHN

Athenahealth

$135.25

-8.005 (-5.59%)

08:43
09/19/18
09/19
08:43
09/19/18
08:43
Recommendations
Athenahealth analyst commentary  »

Leerink sees risk of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEIC

SEI Investments

$62.66

0.26 (0.42%)

08:42
09/19/18
09/19
08:42
09/19/18
08:42
Conference/Events
SEI Investments management to meet with Oppeheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

08:40
09/19/18
09/19
08:40
09/19/18
08:40
Conference/Events
The Atlanta Society of Finance & Investment Professionals to hold a meeting »

The Atlanta Society of…

OCFC

OceanFirst Financial

$28.39

-0.16 (-0.56%)

, SBBX

SB One Bancorp

$26.10

-0.5 (-1.88%)

08:39
09/19/18
09/19
08:39
09/19/18
08:39
Conference/Events
DA Davidson to hold a conference »

The Mid-Atlantic…

OCFC

OceanFirst Financial

$28.39

-0.16 (-0.56%)

SBBX

SB One Bancorp

$26.10

-0.5 (-1.88%)

WSFS

WSFS Financial

$47.93

-0.475 (-0.98%)

MBCN

Middlefield Banc

$47.35

-1.15 (-2.37%)

FFDF

FFD Financial

$0.00

(0.00%)

WSBC

WesBanco

$45.70

-0.74 (-1.59%)

EMCF

Emclaire Financial

$37.00

-0.45 (-1.20%)

TSC

TriState Capital

$28.40

-0.25 (-0.87%)

STBA

S&T Bancorp

$45.27

(0.00%)

SMMF

Summit Financial Group

$24.75

0.39 (1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 24

    Sep

  • 23

    Oct

CSII

Cardiovascular Systems

$38.05

0.47 (1.25%)

08:39
09/19/18
09/19
08:39
09/19/18
08:39
Recommendations
Cardiovascular Systems analyst commentary  »

Cardiovascular Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.